Prothena Corporation PLC (NASDAQ:PRTA)
| 61.19 BATS BZX Real-Time Price As of 10:45am ET |  -0.54 / -0.87%Today’s Change | 21.06 Today|||52-Week Range 74.32 | +23.87% Year-to-Date |
Latest PRTA News | Press Releases
| LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data Sep 29 / Zacks.com - Paid Partner Content | Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today Sep 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 61.73 |
| Today’s open | 63.25 |
| Day’s range | 60.97 - 63.25 |
| Volume | 8,117 |
| Average volume (3 months) | 567,250 |
| Market cap | $2.8B |
Data as of 10:45am ET, 10/04/2022
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -329.23% |
| Earnings growth (next 5 years) | -6.20% |
| Revenue growth (last year) | +23,414.30% |
| P/E ratio | NM |
| Price/Sales | 11.94 |
| Price/Book | 6.07 |
Financials
| Next reporting date | November 8, 2022 |
| EPS forecast (this quarter) | -$0.59 |
| Annual revenue (last year) | $200.6M |
| Annual profit (last year) | $67.0M |
| Net profit margin | 33.39% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Dun Laoghaire, Dublin |
Forecasts
